Nope. Still holding and nursing the wound. Is a lot of info and misinformation abounding. The 12 month data looked good and the 24 month data was also decent, just not stat significant I guess. It's confusing as from what i've read so far, copaxone takes 8-9 months to kick in, so if it shows great results in the 12 month trial, then that should be really attributed to estriol moreso and copaxone. Then the 24 month might be misleading because in the months of 10-24, the copaxone kicks in more and it wouldn't show as much of a difference.
I don't think I'm explaining it well, and it all may be moot anyway. But I guess my point is, it had good 12 month data and they may be able to partner with someone somehow and have a few other things in the pipeline. All mumbo jumbo speak for...am looking for answers :)
This is one of those where, the results seem good for patients, just not good for the markets and is a bad time for Bios still.
I'll have good trades and bad ones. Risk/reward. Will examine this one a lot later when its all said and done. Until then, back to business and find some more winners and of course...
Go ELTP !
These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.
